Nothing Special   »   [go: up one dir, main page]

NO148887C - PROCEDURE FOR THE PREPARATION OF THE CRYSTALLINIC ANHYDRATED BY SODIUM CEFAMANDOL - Google Patents

PROCEDURE FOR THE PREPARATION OF THE CRYSTALLINIC ANHYDRATED BY SODIUM CEFAMANDOL

Info

Publication number
NO148887C
NO148887C NO764222A NO764222A NO148887C NO 148887 C NO148887 C NO 148887C NO 764222 A NO764222 A NO 764222A NO 764222 A NO764222 A NO 764222A NO 148887 C NO148887 C NO 148887C
Authority
NO
Norway
Prior art keywords
crystallinic
anhydrated
procedure
preparation
cefamandol
Prior art date
Application number
NO764222A
Other languages
Norwegian (no)
Other versions
NO764222L (en
NO148887B (en
Inventor
Kuo Shang Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO764222L publication Critical patent/NO764222L/no
Publication of NO148887B publication Critical patent/NO148887B/en
Publication of NO148887C publication Critical patent/NO148887C/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO764222A 1975-12-22 1976-12-13 PROCEDURE FOR THE PREPARATION OF THE CRYSTALLINIC ANHYDRATED BY SODIUM CEFAMANDOL NO148887C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/642,922 US4054738A (en) 1975-12-22 1975-12-22 Sodium cefamandole crystalline forms

Publications (3)

Publication Number Publication Date
NO764222L NO764222L (en) 1977-06-23
NO148887B NO148887B (en) 1983-09-26
NO148887C true NO148887C (en) 1984-01-04

Family

ID=24578600

Family Applications (1)

Application Number Title Priority Date Filing Date
NO764222A NO148887C (en) 1975-12-22 1976-12-13 PROCEDURE FOR THE PREPARATION OF THE CRYSTALLINIC ANHYDRATED BY SODIUM CEFAMANDOL

Country Status (31)

Country Link
US (1) US4054738A (en)
JP (2) JPS5282714A (en)
AR (1) AR213300A1 (en)
AT (2) AT349148B (en)
AU (1) AU505924B2 (en)
BE (1) BE849415A (en)
CA (1) CA1080696A (en)
CH (1) CH628348A5 (en)
CS (1) CS195746B2 (en)
DD (1) DD128727A5 (en)
DE (1) DE2654647C2 (en)
DK (1) DK153156C (en)
FI (1) FI66008C (en)
FR (3) FR2361898A1 (en)
GB (1) GB1565854A (en)
GR (1) GR65891B (en)
HU (1) HU172474B (en)
IL (3) IL50977A (en)
LU (1) LU76435A1 (en)
MX (1) MX3840E (en)
NL (1) NL187483C (en)
NO (1) NO148887C (en)
NZ (1) NZ182694A (en)
OA (1) OA05518A (en)
PH (1) PH12191A (en)
PL (1) PL102739B1 (en)
PT (1) PT65955B (en)
RO (3) RO75963A (en)
SE (3) SE424730B (en)
SU (3) SU637087A3 (en)
ZA (1) ZA766957B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4168376A (en) * 1978-06-05 1979-09-18 Eli Lilly And Company Process for crystalline sodium cefamandole
US4237279A (en) * 1979-07-27 1980-12-02 Eli Lilly And Company Crystalline 3-hydroxycephalosporin solvates
DE3313816A1 (en) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt NEW CEFTAZIDIM CRYSTAL MODIFICATION
DE3313818A1 (en) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt NEW CEFTAZIDIM CRYSTAL MODIFICATION
CA1242699A (en) * 1985-02-01 1988-10-04 Bristol-Myers Company Cefbuperazone and derivatives thereof
JPH0677411B2 (en) * 1985-05-03 1994-09-28 株式会社フジクラ Power cable for high voltage DC transmission
JPS629495U (en) * 1985-07-01 1987-01-21
GB9717629D0 (en) 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3496171A (en) * 1969-02-17 1970-02-17 Lilly Co Eli Process for improving the physical and chemical properties of cephaloglycin
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
US3692781A (en) * 1971-02-26 1972-09-19 Glaxo Lab Ltd Recovery of pure cephalexin from acidic reaction mixtures
US3819620A (en) * 1972-06-01 1974-06-25 Squibb & Sons Inc 7-(d-alpha-amino-1,4-cyclohexadien-1-ylacet-amido)desacetoxycephalosporanic acid dihydrate
US3862186A (en) * 1972-12-15 1975-01-21 Bristol Myers Co Process for the production of cephalexin monohydrate
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions

Also Published As

Publication number Publication date
DE2654647A1 (en) 1977-06-30
US4054738A (en) 1977-10-18
FR2351984B1 (en) 1980-06-27
HU172474B (en) 1978-09-28
FI66008C (en) 1984-08-10
GB1565854A (en) 1980-04-23
AT349148B (en) 1979-03-26
DE2654647C2 (en) 1982-06-24
SE8201701L (en) 1982-03-17
ATA217578A (en) 1978-08-15
MX3840E (en) 1981-08-11
SU671732A3 (en) 1979-06-30
SE8201702L (en) 1982-03-17
CS195746B2 (en) 1980-02-29
GR65891B (en) 1980-12-01
DK575576A (en) 1977-06-23
NL187483C (en) 1991-10-16
NO764222L (en) 1977-06-23
DK153156B (en) 1988-06-20
SE424730B (en) 1982-08-09
FI66008B (en) 1984-04-30
PH12191A (en) 1978-11-21
AR213300A1 (en) 1979-01-15
SE443564B (en) 1986-03-03
BE849415A (en) 1977-06-15
PT65955B (en) 1978-06-15
FR2361898A1 (en) 1978-03-17
FR2361898B1 (en) 1980-03-14
AU505924B2 (en) 1979-12-06
AU2001376A (en) 1978-06-01
PT65955A (en) 1977-01-01
RO69709A (en) 1980-04-15
SE7614401L (en) 1977-06-23
NZ182694A (en) 1978-09-25
JPS61351B2 (en) 1986-01-08
FR2351984A1 (en) 1977-12-16
FR2351985A1 (en) 1977-12-16
IL57386A0 (en) 1979-09-30
PL102739B1 (en) 1979-04-30
NL7614233A (en) 1977-06-24
IL50977A (en) 1980-02-29
DK153156C (en) 1989-02-20
CA1080696A (en) 1980-07-01
FI763682A (en) 1977-06-23
NL187483B (en) 1991-05-16
IL57387A0 (en) 1979-09-30
SU637087A3 (en) 1978-12-05
IL50977A0 (en) 1977-01-31
JPS5282714A (en) 1977-07-11
NO148887B (en) 1983-09-26
ATA948976A (en) 1978-07-15
RO75963A (en) 1981-02-28
JPS6183189A (en) 1986-04-26
ZA766957B (en) 1978-06-28
AT348678B (en) 1979-02-26
JPS624393B2 (en) 1987-01-30
OA05518A (en) 1981-04-30
SU1018585A3 (en) 1983-05-15
FR2351985B1 (en) 1980-06-27
CH628348A5 (en) 1982-02-26
RO75964A (en) 1981-02-28
SE441096B (en) 1985-09-09
LU76435A1 (en) 1977-06-10
DD128727A5 (en) 1977-12-07

Similar Documents

Publication Publication Date Title
SE433208B (en) PROCEDURE FOR THE PREPARATION OF PHENOLETERS
RO72997A (en) PROCEDURE FOR PREPARATION OF BENZOYLURIDIDE-NITRO-DIFENYLETHYL
SE7605139L (en) PROCEDURE FOR THE PREPARATION OF WATER-INTAKING CELLULOSAETERS
SE430336B (en) IMPROVED PROCEDURE FOR THE PREPARATION OF AMOXICILLIN-FREEHYDRATE
AR217629A1 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF TIENOTETRAHIDROPIRIDINA
AR211273A1 (en) PROCEDURE FOR THE PREPARATION OF NEW (PHENOXY-4-PHENYL) 1-PIPERAZINES
NO146022C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE BENZOFENO DERIVATIVES
NO148887C (en) PROCEDURE FOR THE PREPARATION OF THE CRYSTALLINIC ANHYDRATED BY SODIUM CEFAMANDOL
NO141893C (en) PROCEDURE FOR THE PREPARATION OF PERCARBOXYLIC ACID SOLUTIONS
NO139555C (en) PROCEDURE FOR PREPARATION OF FOSGEN
SE7606116L (en) PROCEDURE FOR THE PREPARATION OF 3-PHENOXIDE BENZALDEHIDS
SE7604781L (en) PROCEDURE FOR THE PREPARATION OF DIARYLHYDROXIBUTYLAMINES
SE421793B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF NAFTYRIDINE-SUBSTITUTED PYRROLLER DERIVATIVES
SE404186B (en) PROCEDURE FOR THE PREPARATION OF CYCLOPROPANEL DERIVATIVES
SE7607322L (en) PROCEDURE FOR THE PREPARATION OF 16-ETHARS OF FUSIDIC ACID DERIVATIVES
SE423814B (en) PROCEDURE FOR THE PREPARATION OF DIBENSOFENAZINE OR ACENAPHTOKINOXALIN DERIVATIVES
SE446726B (en) PROCEDURE FOR THE PREPARATION OF 16-METOXIPROSTAGLANDINES
SE7610637L (en) PROCEDURE FOR THE PREPARATION OF 2-ALKYLINDANES
SE7607026L (en) PROCEDURE FOR THE PREPARATION OF 5-ALKYLPICOLIC ACID
SE7605427L (en) PROCEDURE FOR THE PREPARATION OF CHLORCYANE
SE427037B (en) PROCEDURE FOR THE PREPARATION OF DEOXICLAVULANIC ACID
SE7603682L (en) PROCEDURE FOR THE PREPARATION OF AN ETHERIALLY SUBSTITUTED MONOSACCARIDE
DK157761C (en) PROCEDURE FOR THE PREPARATION OF THE CRYSTALLINIC ANHYDRATED BY SODIUM CEFAMANDOL
NO148298C (en) PROCEDURE FOR THE PREPARATION OF AMINOCYCLYLITOL COMPOUNDS
SE409718B (en) PROCEDURE FOR THE PREPARATION OF 6-AMINOMETHYLERADE-3-OXYGENERADE-CHOLEST-5-ENES